We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
-5.08%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$4.82B
AUM Growth
-$690M
Cap. Flow
-$124M
Cap. Flow %
-2.58%
Top 10 Hldgs %
17.51%
Holding
1,588
New
254
Increased
693
Reduced
409
Closed
141

Top Buys

Rank Stock Value
1
DIDI
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
+$50.6M
2
CAT icon
Caterpillar
CAT
+$27M
3
ADI icon
Analog Devices
ADI
+$22.8M
4
CSX icon
CSX Corp
CSX
+$20.1M
5
PTY icon
PIMCO Corporate & Income Opportunity Fund
PTY
+$15M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$24.6M
2
BCX icon
BlackRock Resources & Commodities Strategy Trust
BCX
+$22.3M
3
MXIM
Maxim Integrated Products
MXIM
+$21.2M
4
NFJ
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
+$21.1M
5
VVR icon
Invesco Senior Income Trust
VVR
+$19.6M

Sector Composition

Rank Sector Weight
1 Technology 27.8%
2 Consumer Discretionary 25.32%
3 Communication Services 11.6%
4 Industrials 6.01%
5 Financials 5.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKUS
1376
DELISTED
Akouos Inc
AKUS
$9K ﹤0.01%
785
– –
AUTL
1377
Autolus Therapeutics
AUTL
$562M
$8K ﹤0.01%
1,305
+75
+6% +$474
BLK icon
1378
Blackrock
BLK
$176B
$8K ﹤0.01%
+10
New +$8.96K
CVGW
1379
DELISTED
Calavo Growers
CVGW
$8K ﹤0.01%
234
– –
KNSA icon
1380
Kiniksa Pharmaceuticals
KNSA
$5.93B
$8K ﹤0.01%
745
+10
+1% +$130
OTLY
1381
Oatly Group
OTLY
$438M
$8K ﹤0.01%
28
– –
SYRE icon
1382
Spyre Therapeutics
SYRE
$9.25B
$8K ﹤0.01%
45
– –
TCRT icon
1383
Alaunos Therapeutics
TCRT
$4.86M
$8K ﹤0.01%
33
– –
URGN icon
1384
UroGen Pharma
URGN
$2.29B
$8K ﹤0.01%
510
– –
WKHS icon
1385
Workhorse Group
WKHS
$36.3M
– –
0
– –
SPPI
1386
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$8K ﹤0.01%
3,755
+80
+2% +$219
JNCE
1387
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$8K ﹤0.01%
1,170
+5
+0.4% +$31
BDSI
1388
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$8K ﹤0.01%
2,255
+10
+0.4% +$38
BDTX icon
1389
Black Diamond Therapeutics
BDTX
$112M
$7K ﹤0.01%
830
+5
+0.6% +$49
CTMX icon
1390
CytomX Therapeutics
CTMX
$754M
$7K ﹤0.01%
1,490
+10
+0.7% +$54
ESPR
1391
DELISTED
Esperion Therapeutics
ESPR
$7K ﹤0.01%
645
+5
+0.8% +$73
NGNE icon
1392
Neurogene
NGNE
$712M
$7K ﹤0.01%
49
+1
+2% +$153
TXMD icon
1393
TherapeuticsMD
TXMD
$24M
$7K ﹤0.01%
194
+15
+8% +$666
WW
1394
DELISTED
WW International
WW
$7K ﹤0.01%
430
– –
FUSN
1395
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$7K ﹤0.01%
980
+15
+2% +$126
SURF
1396
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$7K ﹤0.01%
1,040
+50
+5% +$320
TCRR
1397
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$7K ﹤0.01%
875
+5
+0.6% +$71
ATNX
1398
DELISTED
Athenex, Inc. Common Stock
ATNX
$7K ﹤0.01%
125
+18
+17% +$1.31K
FLXN
1399
DELISTED
Flexion Therapeutics, Inc.
FLXN
$7K ﹤0.01%
1,150
+15
+1% +$93
CABA icon
1400
Cabaletta Bio
CABA
$455M
$6K ﹤0.01%
570
+5
+0.9% +$46
54 55
56
57 58

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Penserra Capital Management held 1,588 positions worth $4.82B, down 13% from $5.51B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Penserra Capital Management's Q3 2021 filing shows 254 new, 693 increased, 409 reduced and 141 closed positions. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 5,364,893 shares worth $41.8M. The largest sale was Baidu, an estimated $24.6M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Penserra Capital Management's largest Q3 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 5,364,893 shares worth $41.8M.
  • Penserra Capital Management added most to Analog Devices in Q3 2021, an estimated $22.8M increase.
  • Penserra Capital Management's biggest Q3 2021 reduction was Baidu, cutting an estimated $24.6M.
  • Penserra Capital Management fully exited BlackRock Resources & Commodities Strategy Trust in Q3 2021, selling an estimated $22.3M.
  • Penserra Capital Management's ten largest holdings make up 18% of its $4.82B portfolio in Q3 2021.
  • Penserra Capital Management opened 254 new positions and closed 141 in Q3 2021.
  • Penserra Capital Management's portfolio value fell 13% quarter-over-quarter to $4.82B.

Based on Penserra Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.